Related Experiment Video
Updated: Oct 8, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
miR-27b attenuates dexamethasone-inhibited proliferation and osteoblastic differentiation in MC3T3-E1 cells by
Huicheng Lv1, Tieyi Yang1, Aimin He1
1Second Department of Trauma, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010000, P.R. China.
Abstract:
Osteoporosis is a metabolic bone illness characterized by low bone density and a high risk of fracture. It is estimated that there are >60 million individuals in China suffering from this disease, which highlights an urgent requirement for the development of novel and safe drugs for the long-term treatment of osteoporosis. MicroRNAs (miRNAs/miRs) have previously been identified as critical regulators in the progression of osteoporosis. As an intronic miRNA, miR-27b enhances the osteoblastic differentiation of stem cells from the bone marrow and the maxillary sinus membrane. However, the mechanism underlying miR-27b in osteoporosis remains to be elucidated. In the present study, MC3T3-E1 pre-osteoblasts were treated with dexamethasone (DEX) to establish an in vitro model of osteoporosis. The results of the present study demonstrated that DEX treatment markedly inhibited the viability of MC3T3-E1 cells, and downregulated the expression level of miR-27b. The results of reverse transcription-quantitative PCR, western blotting and dual-luciferase assays revealed that miR-27b directly regulated and suppressed the expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) in MC3T3-E1 cells. Furthermore, overexpression of miR-27b by transfection of cells with miR-27b mimic attenuated DEX-mediated inhibition of cell viability, alkaline phosphatase (ALP) activity and the expression levels of bone morphogenetic protein-2 (BMP2), runt-related protein 2 (Runx2) and osteocalcin (OCN). The results of the present study indicated that miR-27b alleviated DEX-inhibited proliferation and osteoblastic differentiation. Moreover, miR-27b knockdown repressed MC3T3-E1 cell viability, ALP activity and protein levels of BMP2, Runx2 and OCN. However, these effects were abrogated by small interfering RNA-mediated PPARγ2 silencing. In conclusion, the results of the present study demonstrated that miR-27b attenuated DEX-inhibited proliferation and osteoblastic differentiation in MC3T3-E1 pre-osteoblasts by targeting PPARγ2.
Insights
MicroRNA-27b (miR-27b) protects against osteoporosis by enhancing osteoblast differentiation. It targets PPARγ2, counteracting dexamethasone
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Osteoporosis is a prevalent metabolic bone disease with a high fracture risk, affecting millions globally.
- MicroRNAs (miRNAs) are key regulators in osteoporosis pathogenesis.
- miR-27b promotes osteoblastic differentiation, but its role in osteoporosis requires further investigation.
Purpose of the Study:
- To investigate the mechanism of miR-27b in an in vitro osteoporosis model.
- To determine if miR-27b targets peroxisome proliferator-activated receptor γ2 (PPARγ2).
Main Methods:
- Established an in vitro osteoporosis model using MC3T3-E1 pre-osteoblasts treated with dexamethasone (DEX).
- Utilized reverse transcription-quantitative PCR, western blotting, and dual-luciferase assays.
- Employed miR-27b mimics and small interfering RNA (siRNA) for gene manipulation.
Main Results:
- DEX treatment reduced cell viability and miR-27b expression.
- miR-27b directly targeted and suppressed PPARγ2 expression.
- Overexpression of miR-27b reversed DEX-induced inhibition of cell viability, alkaline phosphatase (ALP) activity, and osteoblastic markers (BMP2, Runx2, OCN).
- miR-27b knockdown impaired osteoblast differentiation, an effect reversed by PPARγ2 silencing.
Conclusions:
- miR-27b attenuates DEX-induced inhibition of proliferation and osteoblastic differentiation in pre-osteoblasts.
- This protective effect is mediated through the direct targeting of PPARγ2.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators

